株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

うっ血性心不全:世界の治験動向

Congestive Heart Failure (Heart Failure) Global Clinical Trials Review, H1, 2017

発行 GlobalData 商品コード 201076
出版日 ページ情報 英文 1037 Pages
即納可能
価格
本日の銀行送金レート: 1USD=113.97円で換算しております。
Back to Top
うっ血性心不全:世界の治験動向 Congestive Heart Failure (Heart Failure) Global Clinical Trials Review, H1, 2017
出版日: 2017年06月30日 ページ情報: 英文 1037 Pages
概要

当レポートでは、うっ血性心不全治療薬に関する治験の動向を調査しており、治験件数および被験者数、段階別の状況、有望企業、開発中の治療薬の情報、治験プロファイルなどについて、体系的な情報を提供しています。

当レポートの概要

各地域における治験状況

  • 各国の治験件数と平均被験者数
    • アジア太平洋地域の主要5ヶ国における治験件数
    • 欧州の主要5ヶ国における治験件数
    • 北米の主要国における治験件数
    • 中東・アフリカの主要5カ国における治験件数
    • 中南米の主要5カ国における治験件数

G7諸国での治験件数:心血管疾患治療薬の治験におけるうっ血性心不全の割合

G7諸国における段階別の治験件数

G7諸国での治験件数:進捗状況別

E7諸国での治験件数:心血管疾患治療薬の治験におけるうっ血性心不全の割合

E7諸国における段階別の治験件数

E7諸国での治験件数:進捗状況別

段階別の治験件数

  • 進行中の治験:段階別

進捗状況別の治験件数

治験の目標の達成状況

一定期間に採用された被験者

スポンサーの種類別の治験件数

有望なスポンサー

うっ血性心不全治療薬の治験に携わっている主要企業

有望な薬剤

最新の治験ニュース

治験プロファイルの概要

付録

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GDHC4331CTIDB

GlobalData's clinical trial report, "Congestive Heart Failure (Heart Failure) Global Clinical Trials Review, H1, 2017" provides an overview of Congestive Heart Failure (Heart Failure) clinical trials scenario. This report provides top line data relating to the clinical trials on Congestive Heart Failure (Heart Failure). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents

Table of Contents 2

  • List of Tables 4
  • List of Figures 5
  • Report Guidance 6
  • GlobalData Clinical Trials Report Coverage 7
  • Clinical Trials by Region 8
  • Clinical Trials and Average Enrollment by Country 9
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
  • Top Five Countries Contributing to Clinical Trials in Europe 12
  • Top Countries Contributing to Clinical Trials in North America 13
  • Top Five Countries Contributing to Clinical Trials in Middle East and Africa 14
  • Top Five Countries Contributing to Clinical Trials in Central and South America 15
  • Clinical Trials by G7 Countries: Proportion of Congestive Heart Failure (Heart Failure) to Cardiovascular Clinical Trials 16
  • Clinical Trials by Phase in G7 Countries 17
  • Clinical Trials in G7 Countries by Trial Status 18
  • Clinical Trials by E7 Countries: Proportion of Congestive Heart Failure (Heart Failure) to Cardiovascular Clinical Trials 19
  • Clinical Trials by Phase in E7 Countries 20
  • Clinical Trials in E7 Countries by Trial Status 21
  • Clinical Trials by Phase 22
  • In Progress Trials by Phase 23
  • Clinical Trials by Trial Status 24
  • Clinical Trials by End Point Status 25
  • Subjects Recruited Over a Period of Time 26
  • Clinical Trials by Sponsor Type 27
  • Prominent Sponsors 28
  • Top Companies Participating in Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials 30
  • Prominent Drugs 32
  • Latest Clinical Trials News on Congestive Heart Failure (Heart Failure) 33
  • May 12, 2017: Capricor Therapeutics Provides Update on ALLSTAR Trial 33
  • May 01, 2017: Cytokinetics Announces Results from Dose Escalation Phase of COSMIC-HF Presented at Heart Failure 2017 33
  • Apr 24, 2017: American Regent Announces Enrollment of First Patient in Phase 3 Trial to Investigate Injectafer (Ferric Carboxymaltose) as Treatment for Heart Failure with Iron Deficiency 34
  • Apr 11, 2017: 'Human Gene Therapy' publishes review of randomized clinical trials of gene transfer for heart failure with reduced ejection fraction 34
  • Clinical Trial Profile Snapshots 35

Appendix 1035

  • Abbreviations 1035
  • Definitions 1035
  • Research Methodology 1036
  • Secondary Research 1036
  • About GlobalData 1037
  • Contact Us 1037
  • Source 1037

List of Tables

List of Tables

  • Congestive Heart Failure (Heart Failure) Therapeutics, Global, Clinical Trials by Region, 2017* 8
  • Congestive Heart Failure (Heart Failure) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 9
  • Congestive Heart Failure (Heart Failure) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 10
  • Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 11
  • Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 12
  • Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials, North America, Top Countries, 2017* 13
  • Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2017* 14
  • Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2017* 15
  • Proportion of Congestive Heart Failure (Heart Failure) to Cardiovascular Clinical Trials, G7 Countries (%), 2017* 16
  • Congestive Heart Failure (Heart Failure) Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 17
  • Congestive Heart Failure (Heart Failure) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 18
  • Proportion of Congestive Heart Failure (Heart Failure) to Cardiovascular Clinical Trials, E7 Countries (%), 2017* 19
  • Congestive Heart Failure (Heart Failure) Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 20
  • Congestive Heart Failure (Heart Failure) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 21
  • Congestive Heart Failure (Heart Failure) Therapeutics, Global, Clinical Trials by Phase, 2017* 22
  • Congestive Heart Failure (Heart Failure) Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 23
  • Congestive Heart Failure (Heart Failure) Therapeutics, Global, Clinical Trials by Trial Status, 2017* 24
  • Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials, Global, by End Point Status, 2017* 25
  • Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 26
  • Congestive Heart Failure (Heart Failure) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 27
  • Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 29
  • Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 31
  • Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 32

List of Figures

List of Figures

  • Congestive Heart Failure (Heart Failure) Therapeutics, Global, Clinical Trials by Region (%), 2017* 8
  • Congestive Heart Failure (Heart Failure) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 9
  • Congestive Heart Failure (Heart Failure) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 10
  • Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017* 11
  • Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 12
  • Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 13
  • Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2017* 14
  • Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2017* 15
  • Proportion of Congestive Heart Failure (Heart Failure) to Cardiovascular Clinical Trials, G7 Countries (%), 2017* 16
  • Congestive Heart Failure (Heart Failure) Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 17
  • Congestive Heart Failure (Heart Failure) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 18
  • Proportion of Congestive Heart Failure (Heart Failure) to Cardiovascular Clinical Trials, E7 Countries (%), 2017* 19
  • Congestive Heart Failure (Heart Failure) Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 20
  • Congestive Heart Failure (Heart Failure) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 21
  • Congestive Heart Failure (Heart Failure) Therapeutics, Global, Clinical Trials by Phase (%), 2017* 22
  • Congestive Heart Failure (Heart Failure) Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 23
  • Congestive Heart Failure (Heart Failure) Therapeutics, Global, Clinical Trials by Trial Status, 2017* 24
  • Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials, Global, by End Point Status, 2017* 25
  • Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 26
  • Congestive Heart Failure (Heart Failure) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 27
  • Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 28
  • Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 30
  • Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 32
  • GlobalData Methodology 1036
Back to Top